Gait Adaptation Study
Integrative Training Approach for Inducing Neuroplasticity in Multiple Sclerosis
What it found
No result yet.
What was tested
Treatment tested
- Gait Adaptation Training
Compared with
- Basic Physical Training
What it measured
Main measures
walking speed
Baseline and after 4 weeks of training and after 4 weeks of the end of training
Walking and mobilityDynamic Gait Index (DGI)
Baseline and after 4 weeks of training and after 4 weeks of the end of training
Walking and mobilityResting-state brain connectivity
Baseline and after 4 weeks of training and after 4 weeks of the end of training
Nerve conduction testsbrain-muscle coherence
Baseline and after 4 weeks of training and after 4 weeks of the end of training
Other measures (3)
6 min walking test
Baseline and after 4 weeks of training and after 4 weeks of the end of training
Walking and mobilityCardiovascular measure
Baseline and after 4 weeks of training and after 4 weeks of the end of training
congition
Baseline and after 4 weeks of training and after 4 weeks of the end of training
Thinking and memory
Who could take part
MS (type not specified) · 18 to 80
Show the full criteria
Inclusion criteria
* Age 18 to 80 yrs Clinically definite MS diagnosis Ability to attend to computer screen and follow instructions in English which will be assessed by MiniMental test requiring a participant to score >24 (out of 30 max score) Right-handed as determined by research diagnostic criteria of the Edinburgh Handedness Inventory (Oldfield 1971) Self report of normal or corrected-to-normal vision Exclusion Criteria Psychiatric disorders, only those requiring treatment because the medications may affect brain activation Neurological disorder that may affect cognition, balance, and/or physical wellness such as brain injury, or stroke. Orthopedic injuries or neuromuscular disorder that may affect balance or mobility Engagement in other cognitive or physical training program while enrolled in this study Ongoing relapse (new or returning neurological symptoms) or steroid treatment during the 30 days preceding enrollment
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
Contact details on the registryAbout this trial
In the sponsor's words
This pilot study proposes a clinical trial to target treatment of sensorimotor and cognitive deficits in persons with Multiple Sclerosis (pwMS). The proposal has the potential to promote neuroplasticity and induce re-normalization in brain to muscle (cortico-muscular) connectivity (BMC) and within brain connectivity via an integrative training approach. Preliminary data and published work are available to inform specific aspects of the proposed trial, along with the general rationale for exploring the suggested rehabilitation approach. However, there is a gap in research on the effects of training that uses the proposed approach via a clinical trial (of any phase) in pwMS to support the rationale for exploring the suggested rehabilitation training approach. Moreover, there is no pilot data on the training itself in the same population. This study will examine the behavioral deficits and neural characteristics in children with MS and two other related conditions (Myelin Oligodendrocyte Glycoprotein (MOG) and Nueromyelitis Optica Spectrum Disorder (NMOSD)) to understand if they would benefit from rehabilitation training conditions tested in aims 1 and 2. The overall long term goal is to improve rehabilitation training conditions for both adults and children with MS.
Loading reviews and guidelines…
History
Started
Jan 2025
Main results due
May 2028
Finished
Jul 2028